NEWS
Givaudan buys Amyris ingredients
As part of its strategy to expand its Active Beauty business , Givaudan , is to acquire some cosmetic ingredients from the US biotech Amyris . They include Neossance Squalane , a high-performance emollient , Neossance Hemisqualane , a plant-based silicone alternative , and CleanScreen , for sun protection . This should be completed in Q1 , subject to regulatory approval . l .
The two have also signed a long-term partnership agreement under which Amyris will continue to manufacture ingredients for Givaudan to use in cosmetics , and provide access to its Lab-to-Market technology and biomanufacturing platforms to develop and manufacture beauty ingredients . Givaudan will become Amyris ’ commercialisation partner in this market .
The terms include an upfront cash payment and a performance-based earnout . No further details were disclosed but Givaudan said that Amyris ’ active cosmetic ingredients business would have represented about $ 30 million of incremental sales to its 2022 results on a pro forma basis . It will fund the deal from existing resources .
Meanwhile , another flavours and fragrances house , Symrise , is to take a minority stake in Israeli biotech Synergio , with the option of owning a majority in future . Synergio develops natural antimicrobial combinations from plants for product protection , using a data-driven , biochemistry-based , computational platform . Symrise is already a major player in this field in the personal care sector .
Also in this field , Croda International has bought Solus Biotech from Korea ’ s Solus Advanced Materials for about $ 277 million on a debt-free , cash-free basis , subject to regulatory approval . Solus Biotech makes biotechnologyderived beauty actives , notably naturally derived powder ceramides and GMP phospholipids for both pharmaceutical and cosmetic applications .
Three collaborate on carbon neutrality
Sumitomo Chemical , Maruzen Petrochemical and Mitsui Chemicals have agreed to study the feasibility of collaborative projects to achieve carbon neutrality at the Keiyo Coastal Industrial Complex in Chiba . This is part of climate change targets all three have developed individually .
The initiative will mainly comprise measures to reduce greenhouse gas emissions , such as diversifying feedstocks , using biomass , new chemical recycling and material recycling technologies , converting to new kinds of fuels and the renewal of associated infrastructure .
Keiyo is one of Japan ’ s largest industrial complexes , with many other materials and energy companies active there . The three will also engage with related local governments and companies through such initiatives as the Keiyo Coastal Industrial Complex Council on Carbon Neutrality .
US oil and gas players merge
Imperative Chemical Partners and RSI Chemicals are joining forces to create one of the largest land oil and gas chemical businesses in the US under the joint ownership of Hastings Equity Partners and One Equity Partners . Both are based in Texas .
Imperative was itself formed in 2019 via the merger of three companies and now employs 550 employees at 32 locations across 12 states . It specialises in production and completion chemical , acid stimulation , and capillary injection services for upstream and midstream oil , gas and water applications . Custom chemicals supplier RSI has 270 employees at 20 sites .
Imperative COO Ryan Havens will become CEO , with the current CEO Neil Harrop joining the board . Garrett Tucker , COO at RSI , will have the same role in the combined company . RSI CEO Curtis Bordelon is retiring . The two claim to have a “ complementary regional presence and natural cultural alignment ”, with a full product line for all chemical needs for completions , flowback , production and midstream operations .
11